Article Details
Retrieved on: 2018-05-10 20:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Moreover, <b>Benchmark Capital</b> Advsrs has 0.92% invested in Sarepta Therapeutics, Inc. (NASDAQ:SRPT). 20,463 were reported by Nuveen Asset ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here